Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.
Journal: Leukemia research
Published: February 21, 2022
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.
Journal: Expert review of hematology
Published: June 02, 2021
Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia.
Journal: Future oncology (London, England)
Published: May 24, 2021
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center.
Journal: Frontiers in oncology
Published: January 04, 2021
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 31, 2020
Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 03, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026